Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Aso Author Reflections: Potential Of Peripheral Plasma Exosomal Mirna: Mir-6855-5p Could Predict Radiosensitivity In Patients With Pancreatic Cancer, And Enhances Radioresistance

ASO Author Reflections: Potential of Peripheral Plasma Exosomal miRNA: miR-6855-5p Could Predict Radiosensitivity in Patients with Pancreatic Cancer, and Enhances Radioresistance

Hiroki Ueda1, Hidenori Takahashi2, Shogo Kobayashi1

  • 1Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

Annals of Surgical Oncology
|September 19, 2024

Related Experiment Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.5K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.6K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.3K

View abstract on PubMed

Summary
This summary is machine-generated.

Researchers identified miR-6855-5p in pancreatic cancer (PC) patient exosomes. Higher levels of this microRNA correlate with increased radioresistance, suggesting its potential as a biomarker for personalized preoperative treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarkers

Background:

  • Preoperative treatment for pancreatic cancer (PC) efficacy is debated, with controversy surrounding optimal regimens and the addition of radiotherapy.
  • Personalizing neoadjuvant therapy based on individual tumor biology is crucial for maximizing treatment outcomes.
  • Biomarkers are needed to predict treatment response and guide therapeutic decisions in PC.

Purpose of the Study:

  • To identify potential biomarkers in peripheral blood plasma exosomes for predicting preoperative treatment efficacy in pancreatic cancer.
  • To investigate the role of specific microRNAs (miRNAs) in mediating radioresistance in PC cells.
  • To explore the clinical relevance of candidate miRNAs in relation to patient response to neoadjuvant chemoradiotherapy.

Main Methods:

Related Experiment Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.5K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.6K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.3K
  • MicroRNA (miRNA) microarray analysis was conducted on peripheral blood plasma exosomes from 10 PC patients undergoing neoadjuvant chemoradiotherapy.
  • In vitro experiments assessed the effect of the candidate miRNA, miR-6855-5p, on radioresistance in PC cell lines.
  • Exosomal miR-6855-5p expression levels were quantified in a cohort of 28 PC patients and correlated with radioresistance.

    • Main Results:

    • miR-6855-5p was identified as a candidate miRNA from exosome analysis.
    • Overexpression of miR-6855-5p was demonstrated to induce radioresistance in pancreatic cancer cells.
    • A significant negative correlation (r = -0.5964) was observed between higher plasma exosomal miR-6855-5p levels and increased radioresistance in patients.

    Conclusions:

    • Plasma exosomal miR-6855-5p may serve as a predictive biomarker for radioresistance in pancreatic cancer.
    • Measuring miR-6855-5p levels pre-treatment could enable personalized therapeutic strategies, potentially guiding the inclusion of radiotherapy.
    • This finding supports the development of precision medicine approaches for optimizing pancreatic cancer neoadjuvant treatment.